Plasma Masterclass Learners’ Questionnaire Plasma Masterclass 2026 February 6-7, 2026, Abu Dhabi Step 1 of 2 50% Dear 2026 Plasma Masterclass Participant, To receive your EBAH-CME accreditation points for attending the 2026 Plasma Masterclass, February 6-7, 2026, Abu Dhabi, please complete the following learner’s questionnaire. Should you have any questions, please contact: [email protected], or [email protected]. Many thanks, The IACH Secretariat on behalf of the Plasma OrganizersCOURSE EVALUATION:1. This event has fulfilled my educational goals and my expected learning outcomes 5 – Agree 4 3 – Neutral 2 1 – Disagree 2. I have learned information at this event that will help me to improve my practice 5 – Agree 4 3 – Neutral 2 1 – Disagree 3. The education provided at this event consistently was very good or excellent 5 – Agree 4 3 – Neutral 2 1 – Disagree 4. There was sufficient time for discussions, questions & answers and learner engagement 5 – Agree 4 3 – Neutral 2 1 – Disagree 5. The information presented consistently was supported by a valid scientific evidence base 5 – Agree 4 3 – Neutral 2 1 – Disagree 6. The speakers consistently were very good or excellent 5 – Agree 4 3 – Neutral 2 1 – Disagree 7. There was no bias in any of the programmed educational events 5 – Agree 4 3 – Neutral 2 1 – Disagree Comments:PROGRAM EVALUATION:State-of-the-art therapy for transplant-eligible MM patientsFriday – February 6th 14:40-15:15 Did you attend this session? Yes No What was presented in this session and what is your key take-away?Roundtable discussion: therapy of transplant-eligible MM patientsFriday – February 6th 15:15-16:00 Did you attend this session? Yes No What was presented in this session and what is your key take-away?State-of-the-art therapy for non-transplant eligible MM patientsFriday – February 6th 17:00-17:45 Did you attend this session? Yes No What was presented in this session and what is your key take-away?Roundtable discussion: therapy of non-transplant eligible MM patientsFriday – February 6th 17:45-18:30 Did you attend this session? Yes No What was presented in this session and what is your key take-away?Management of relapsed/refractory myeloma patientsSaturday – February 7th 08:30-09:15 Did you attend this session? Yes No What was presented in this session and what is your key take-away?Roundtable discussion: management of RRMM patientsSaturday – February 7th 09:15-10:00 Did you attend this session? Yes No What was presented in this session and what is your key take-away?Guidelines on management in multiple myeloma in the relapsed/refractory setting: the Saudi Myeloma Working Group GuidelinesSaturday – February 7th 11:00-11:45 Did you attend this session? Yes No What was presented in this session and what is your key take-away?Management of MM patients in real life: live discussion based on clinical casesSaturday – February 7th 11:45-13:00 Did you attend this session? Yes No What was presented in this session and what is your key take-away? Personal InformationConsent(Required) I hereby confirm the completed form is correct and that I actively attended the 2026 Plasma Masterclass scientific sessions as marked herein(Required)Date(Required) MM slash DD slash YYYY SignatureTitle(Required)First name(Required)Last name(Required)Country of origin(Required)Please selectAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland IslandsEBAH Member number(Required)Email address(Required)